Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. AAPL
2. BRZE
3. TTAN
4. CHYM
5. USO
6. COO
7. QCOM
8. IRT
9. AEO
10. MSI

Go back to Teva and Alvotech Announce Strategic Partnership to Collaborate in the U.S. Biosimilar Market

Teva Pharma (TEVA) PT Raised to $11 at Cowen

August 5, 2020 1:04 PM EDT

Cowen analyst Ken Cacciatore raised the price target on Teva Pharma (NYSE: TEVA) to $11.00 (from $9.00) while maintaining a Market Perform rating.

The analyst commented, "Teva is performing as well as can be expected, with good cost reductions while still executing on the Austedo... More